Hebrew University of Jerusalem’s Prof Haitham Amal (see here previously) is the only non-USA member of a new consortium focused on pioneering autism research. It has just been awarded a research grant of $17 million by the California Institute for … Continue reading →

Hebrew University of Jerusalem Professor Haitham Amal has received a $400k grant from the Philadelphia Eagles Autism Foundation to develop treatments based on his nitric oxide research for autism spectrum disorder (ASD). Amal is the first researcher outside the US … Continue reading →

The American Friends of the Hebrew University is hosting an evening with the University’s Dr Haitham Amal on 31 Jan in Florida. Dr Amal will discuss the groundbreaking development of therapies for Autism and Alzheimer’s disease. https://www.afhu.org/event/towards-the-groundbreaking-development-of-therapeutic-drugs-for-autism-and-alzheimers-disease/